Dr. Lisa Prendergast is the Associate Director of Expression System Sciences in Licensing at Lonza. Her role is to provide global support with in-depth scientific and technical direction to those working with Lonza’s GS Gene Expression System®. She is an expert in Cell and Molecular Biology including vector based gene expression systems and the sequence based technologies supporting the development of complex biologicals.
Dr. Prendergast has extensive academic discovery research experience from her postdoctoral work in Ireland, France and the UK. As a Senior Research Associate and Lead Biologist for Cancer Researck UK she worked within target validation for early stage oncology drug discovery programmes. Prior to joining Lonza she supported the pandemic response with the scale up of the UK National COVID-19 testing infrastrucure. She holds a Ph.D. in Biochemistry from the National University of Ireland, Galway.